A new perspective on Alzheimer's disease: m6A modification

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alzheimer's disease (AD) involves synaptic loss, amyloid plaques, tau pathology, and neuroinflammation.
• Epitranscriptomic modifications, particularly N6-methyladenosine (m6A), regulate mRNA metabolism and gene expression.
• Dysregulation of m6A modification in the nervous system is implicated in AD pathogenesis.

Purpose of the Study:

• To review recent advances in understanding m6A modification regulatory mechanisms in AD.
• To discuss current research techniques for m6A and AD animal models.
• To explore the potential of epitranscriptomic studies for AD pathogenesis, early diagnosis, and treatment.

Main Methods:

• Literature review of recent research on m6A modification and Alzheimer's disease.
• Analysis of studies utilizing animal models for m6A and AD research.
• Exploration of emerging research techniques in epitranscriptomics.

Main Results:

• The review synthesizes current knowledge on the role of m6A in AD development.
• It highlights the utility of m6A-focused animal models in studying AD.
• The potential for epitranscriptomic approaches in AD research is discussed.

Conclusions:

• m6A modification plays a significant role in the nervous system's response to AD.
• Epitranscriptomic analysis offers promising strategies for early AD detection.
• Targeting m6A pathways presents potential therapeutic avenues for Alzheimer's disease.